An open‐label, long‐term extension, multicenter study to evaluate the safety and efficacy of venlafaxine extended release in Japanese outpatients with generalized anxiety disorder
Psychiatry and Clinical Neurosciences Reports · 2026-09 · 5 (3)
DOI: 10.1002/pcn5.70371 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychiatry and Clinical Neurosciences Reports, online erschienen am 06.07.2026. Verfasst von Tempei Otsubo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychosomatic and Psychiatric Medicine Tokyo Women's Medical University Adachi Medical Center Tokyo Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Aim
This study evaluated the long‐term safety and efficacy of venlafaxine extended release (ER), which has been administered for 52 weeks in Japanese adult outpatients with generalized anxiety disorder (GAD).
Methods
In this open‐label, long‐term extension, multicenter study, 135 Japanese patients with GAD were enrolled after completing 10 weeks of treatment with venlafaxine ER or placebo (including tapering) during the preceding placebo‐controlled, double‐blind study. Venlafaxine ER 75–225 mg/day was to be administered to all participants for 52 weeks in this study. Primary endpoints were the incidence of adverse events and suicidal ideation/behavior. Secondary endpoints included scores of the Hamilton Anxiety Rating Scale (HAM‐A), Clinical Global Impressions‐Severity of Illness (CGI‐S), and Clinical Global Impressions‐Global Improvement (CGI‐I).
Results
Venlafaxine ER was overall well‐tolerated. Reported adverse events were in line with those reported in the preceding placebo‐controlled, double‐blind study. No serious adverse events or deaths were reported, and no tendency of venlafaxine ER to induce suicidal ideation was observed. No new safety findings were identified. A constant and consistent decrease in mean HAM‐A total scores was observed (baseline: 15.9; Week 52: 8.0), as evidenced by a more pronounced change from baseline. Similar improvements were also observed in CGI‐S and CGI‐I scores, suggesting the effectiveness of venlafaxine ER with long‐term use.
Conclusion
The overall safety profile with long‐term use of venlafaxine ER was consistent with the one previously observed, confirming the safety of long‐term use of venlafaxine ER in Japanese adult patients with GAD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychosomatic and Psychiatric Medicine Tokyo Women's Medical University Adachi Medical Center Tokyo Japan.
- Department of Neuropsychiatry Kyorin University School of Medicine Tokyo Japan.
- Department of Psychiatry Sapporo Hanazono Hospital Sapporo Japan.
- Department of Psychiatry Tokyo Medical University Tokyo Japan.
- Department of Education, College of Education, Psychology and Human Studies/Health Administration Center Aoyama Gakuin University Tokyo Japan.
- Department of Neuropsychiatry Keio University School of Medicine Tokyo Japan.
ORCID-Profile: Keisuke Nomoto
Zitieren
APA
Otsubo, T., Watanabe, K., Inoue, T., Inagaki, A., Kikuchi, T., Nomoto, K., Higa, S., Asami, Y., Sun, B., & Marschall, K. (2026). An open‐label, long‐term extension, multicenter study to evaluate the safety and efficacy of venlafaxine extended release in Japanese outpatients with generalized anxiety disorder. Psychiatry and Clinical Neurosciences Reports, 5(3). https://doi.org/10.1002/pcn5.70371
Vancouver
Otsubo T, Watanabe K, Inoue T, Inagaki A, Kikuchi T, Nomoto K, et al. An open‐label, long‐term extension, multicenter study to evaluate the safety and efficacy of venlafaxine extended release in Japanese outpatients with generalized anxiety disorder. Psychiatry and Clinical Neurosciences Reports. 2026;5(3). doi:10.1002/pcn5.70371
BibTeX
@article{Otsubo2026,
author = {Otsubo, Tempei and Watanabe, Koichiro and Inoue, Takeshi and Inagaki, Ataru and Kikuchi, Toshiaki and Nomoto, Keisuke and Higa, Shingo and Asami, Yuko and Sun, Bin and Marschall, Kristina},
title = {An open‐label, long‐term extension, multicenter study to evaluate the safety and efficacy of venlafaxine extended release in Japanese outpatients with generalized anxiety disorder},
journal = {Psychiatry and Clinical Neurosciences Reports},
year = {2026},
volume = {5},
number = {3},
doi = {10.1002/pcn5.70371}
}
EUVIMED